Literature DB >> 20544321

Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities.

Chigusa Sawamura1, Dempsey S Springfield, Karen J Marcus, Antonio R Perez-Atayde, Mark C Gebhardt.   

Abstract

BACKGROUND: Pediatric soft tissue sarcomas are rare and differ from those in adults regarding the spectrum of diagnoses and treatment. Sarcomas in extremities may have different prognoses from those located elsewhere. QUESTIONS/PURPOSES: We sought risk factors predicting local recurrence, metastasis, and overall survival and asked whether radiation and chemotherapy influenced local recurrence, metastasis, and overall survival.
METHODS: We retrospectively reviewed all 98 patients aged 18 years or younger diagnosed with soft tissue sarcomas in extremities from 1990 to 2008. Age, tumor size, depth, location, bone or neurovascular involvement, histologic subtypes, unplanned excision, surgical margins, metastasis at diagnosis, and adjuvant treatments were reviewed for each patient. We determined the effect of each prognostic variable on local recurrence, metastasis, and overall survival.
RESULTS: Ninety-four patients underwent surgical excision and seven patients had local recurrence at a median time of 18.6 months. Radiation therapy reduced the rate of local recurrence. Fourteen patients had metastasis at diagnosis and seven patients later developed metastasis. The median time to metastasis was 20.9 months. Six patients died and the median time to death was 28.0 months. Metastasis at diagnosis was a predictive factor for death.
CONCLUSIONS: When limited to extremities, radiation therapy reduced the rate of local recurrence in pediatric soft tissue sarcomas. Metastases at diagnosis predict death.

Entities:  

Mesh:

Year:  2010        PMID: 20544321      PMCID: PMC2947691          DOI: 10.1007/s11999-010-1398-1

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  23 in total

1.  Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.

Authors:  W M Crist; J R Anderson; J L Meza; C Fryer; R B Raney; F B Ruymann; J Breneman; S J Qualman; E Wiener; M Wharam; T Lobe; B Webber; H M Maurer; S S Donaldson
Journal:  J Clin Oncol       Date:  2001-06-15       Impact factor: 44.544

2.  Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.

Authors:  P W Pisters; D H Leung; J Woodruff; W Shi; M F Brennan
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

3.  Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital.

Authors:  S L Spunt; C A Poquette; Y S Hurt; A M Cain; B N Rao; T E Merchant; J J Jenkins; V M Santana; C B Pratt; A S Pappo
Journal:  J Clin Oncol       Date:  1999-12       Impact factor: 44.544

4.  Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Authors:  Holcombe E Grier; Mark D Krailo; Nancy J Tarbell; Michael P Link; Christopher J H Fryer; Douglas J Pritchard; Mark C Gebhardt; Paul S Dickman; Elizabeth J Perlman; Paul A Meyers; Sarah S Donaldson; Sheila Moore; Aaron R Rausen; Teresa J Vietti; James S Miser
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

5.  Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients.

Authors:  Iyad Sultan; Carlos Rodriguez-Galindo; Raya Saab; Sameer Yasir; Michela Casanova; Andrea Ferrari
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

6.  Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma.

Authors:  Sheri L Spunt; D Ashley Hill; Alison M Motosue; Catherine A Billups; Alvida M Cain; Bhaskar N Rao; Charles B Pratt; Thomas E Merchant; Alberto S Pappo
Journal:  J Clin Oncol       Date:  2002-08-01       Impact factor: 44.544

Review 7.  Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.

Authors:  Andrea Ferrari; Palma Dileo; Michela Casanova; Rossella Bertulli; Cristina Meazza; Lorenza Gandola; Pierina Navarria; Paola Collini; Alessandro Gronchi; Patrizia Olmi; Franca Fossati-Bellani; Paolo G Casali
Journal:  Cancer       Date:  2003-08-01       Impact factor: 6.860

8.  The surgical margin in soft-tissue sarcoma.

Authors:  R S Bell; B O'Sullivan; F F Liu; J Powell; F Langer; V L Fornasier; B Cummings; P N Miceli; N Hawkins; I Quirt
Journal:  J Bone Joint Surg Am       Date:  1989-03       Impact factor: 5.284

9.  Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.

Authors:  S Singer; J M Corson; G D Demetri; E A Healey; K Marcus; T J Eberlein
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

10.  The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival.

Authors:  A T Stotter; R P A'Hern; C Fisher; A F Mott; M E Fallowfield; G Westbury
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

View more
  7 in total

1.  Conditional survival of pediatric, adolescent, and young adult soft tissue sarcoma and bone tumor patients.

Authors:  Judy Y Ou; Holly Spraker-Perlman; Andrew C Dietz; Rochelle R Smits-Seemann; Sapna Kaul; Anne C Kirchhoff
Journal:  Cancer Epidemiol       Date:  2017-10-07       Impact factor: 2.984

2.  What are risk factors for local recurrence of deep high-grade soft-tissue sarcomas?

Authors:  Chigusa Sawamura; Seiichi Matsumoto; Takashi Shimoji; Taisuke Tanizawa; Keisuke Ae
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

3.  Primary flap reconstruction of tissue defects after sarcoma surgery enables curative treatment with acceptable functional results: a 7-year review.

Authors:  Jenny Fabiola López; Kristiina Elisa Hietanen; Ilkka Santeri Kaartinen; Minna Tellervo Kääriäinen; Toni-Karri Pakarinen; Minna Laitinen; Hannu Kuokkanen
Journal:  BMC Surg       Date:  2015-06-09       Impact factor: 2.102

4.  PROGNOSTIC FACTORS IN PATIENTS WITH APPENDICULAR MYXOFIBROSARCOMA.

Authors:  Juan Pablo Zumárraga; Felipe Augusto Ribeiro Batista; André Mathias Baptista; Marcelo Tadeu Caiero; Luis Pablo de la Rosa Martino; Olavo Pires de Camargo
Journal:  Acta Ortop Bras       Date:  2018       Impact factor: 0.513

5.  Impact of surgical margin on survival in extremity soft tissue sarcoma: A systematic review and meta-analysis.

Authors:  Woo Young Jang; Han-Soo Kim; Ilkyu Han
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

6.  Score for the Risk and Overall Survival of Lung Metastasis in Patients First Diagnosed With Soft Tissue Sarcoma: A Novel Nomogram-Based Risk Assessment System.

Authors:  Zhiyi Fan; Changxing Chi; Yuexin Tong; Zhangheng Huang; Youxin Song; Shengjie You
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

7.  Proton Therapy for Primary Bone Malignancy of the Pelvic and Lumbar Region - Data From the Prospective Registries ProReg and KiProReg.

Authors:  Rasin Worawongsakul; Theresa Steinmeier; Yi-Lan Lin; Sebastian Bauer; Jendrik Hardes; Stefanie Hecker-Nolting; Uta Dirksen; Beate Timmermann
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.